title: Human parvovirus B19 infection in pregnancy: should screening be offered to the low-risk population?
abstract: Human parvovirus B19 infection during pregnancy can result in fetal hydrops and death. Intra-uterine transfusion in hydropic fetuses affected by the virus can reduce perinatal deaths. Up to 33% of women with this infection are asymptomatic. In view of the significant adverse outcomes, the role of routine screening among low-risk pregnant women is discussed.
authors.affiliation: Department of Maternal Fetal Medicine, Mater Mothers' Hospital, South Brisbane, Queensland, Australia.
authors.forename: Shell Fean
authors.initials: SF
authors.lastname: Wong
authors.forename: Fung Yee
authors.initials: FY
authors.lastname: Chan
authors.forename: Robert B
authors.initials: RB
authors.lastname: Cincotta
authors.forename: Martin
authors.initials: M
authors.lastname: Tilse
authors.forename: Wong Shell
authors.initials: WS
authors.lastname: Fean
authors.forename: Chan Fung
authors.initials: CF
authors.lastname: Yee
mesh_terms: D001315:Australia; D005260:Female; D006801:Humans; D008403:Mass Screening; D010322:Parvoviridae Infections / Q000175:diagnosis*; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D011295:Prenatal Care; D011296:Prenatal Diagnosis